Aduro Biotech Receives $22.4 Million in Clinical Development Milestone Payments From Janssen
Feb 01, 2016 13:00 pm UTC| Business
BERKELEY, Calif., Feb. 01, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that the company received $22.4 million in clinical development milestone payments from Janssen Biotech, Inc., the company’s license...
Pacific Mercantile Bancorp Reports Fourth Quarter and Fiscal 2015 Operating Results
Feb 01, 2016 13:00 pm UTC| Business
Fourth Quarter Highlights Net income of $12.1 million, or $0.53 per shareTax benefit of $11.6 million attributable to the reversal of the valuation allowance associated with the Company's deferred tax assetTotal...
VBL Therapeutics to Present Corporate Overview at the 18th Annual BIO CEO & Investor Conference
Feb 01, 2016 13:00 pm UTC| Business
TEL AVIV, Israel, Feb. 01, 2016 -- VBL Therapeutics (NASDAQ:VBLT), announced today that Chief Executive Officer, Dror Harats, M.D., will provide a corporate overview and business update at the BIO CEO Investor...
UBIC Announces Grand Opening of Its Managed Review Center at Bryant Park in New York City
Feb 01, 2016 13:00 pm UTC| Business
NEW YORK, Feb. 01, 2016 -- UBIC, Inc. (Nasdaq:UBIC) (TSE:2158), a leading provider of international litigation support and big-data analysis services, announced today that it has opened a new flagship Managed Review...
Feb 01, 2016 13:00 pm UTC| Business
LITTLETON, Colo., Feb. 01, 2016 -- Stillwater Mining Company (NYSE:SWC) reported today that union employees at the Company’s Stillwater Mine and Columbus processing facilities, represented by the USW International Union...
Feb 01, 2016 13:00 pm UTC| Business
LAS VEGAS, Feb. 01, 2016 -- Pinnacle Entertainment, Inc. (NASDAQ:PNK) announced today that it will release its 2015 fourth quarter and full year financial results on Thursday, February 11, 2016 prior to the market...
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
Feb 01, 2016 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 01, 2016 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its...